Gil Blum
Stock Analyst at Needham
(3.78)
# 733
Out of 5,117 analysts
423
Total ratings
40.15%
Success rate
11.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Maintains: Buy | $10 → $11 | $1.86 | +491.40% | 33 | Dec 29, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $80 | $55.15 | +45.06% | 27 | Dec 23, 2025 | |
| MREO Mereo BioPharma Group | Reiterates: Buy | $5 | $0.48 | +940.37% | 20 | Dec 22, 2025 | |
| ABSI Absci | Reiterates: Buy | $7 | $3.74 | +87.17% | 7 | Dec 12, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $17.49 | +48.66% | 28 | Dec 8, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $61.83 | +69.82% | 24 | Dec 8, 2025 | |
| SLDB Solid Biosciences | Initiates: Buy | $16 | $5.33 | +200.19% | 1 | Dec 4, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $9 → $6 | $1.04 | +476.92% | 8 | Nov 4, 2025 | |
| CELC Celcuity | Reiterates: Buy | $70 | $103.80 | -32.56% | 21 | Oct 20, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $10 | $4.89 | +104.50% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $4.17 | +331.65% | 7 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.37 | +83.07% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.90 | +426.32% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $21.07 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.55 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $6.91 | +478.87% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $32.75 | +116.79% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.89 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $13.60 | +252.94% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.32 | +354.55% | 23 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.25 | - | 8 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Buy | $15 | $5.40 | +177.78% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.01 | - | 9 | Oct 27, 2025 |
Autolus Therapeutics
Dec 29, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $1.86
Upside: +491.40%
CRISPR Therapeutics AG
Dec 23, 2025
Reiterates: Buy
Price Target: $80
Current: $55.15
Upside: +45.06%
Mereo BioPharma Group
Dec 22, 2025
Reiterates: Buy
Price Target: $5
Current: $0.48
Upside: +940.37%
Absci
Dec 12, 2025
Reiterates: Buy
Price Target: $7
Current: $3.74
Upside: +87.17%
Nurix Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $26
Current: $17.49
Upside: +48.66%
Arcellx
Dec 8, 2025
Reiterates: Buy
Price Target: $105
Current: $61.83
Upside: +69.82%
Solid Biosciences
Dec 4, 2025
Initiates: Buy
Price Target: $16
Current: $5.33
Upside: +200.19%
TScan Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.04
Upside: +476.92%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $103.80
Upside: -32.56%
Taysha Gene Therapies
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $4.89
Upside: +104.50%
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $4.17
Upside: +331.65%
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $4.37
Upside: +83.07%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.90
Upside: +426.32%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $21.07
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.55
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $6.91
Upside: +478.87%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $32.75
Upside: +116.79%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.89
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $13.60
Upside: +252.94%
Jul 26, 2024
Reiterates: Buy
Price Target: $6
Current: $1.32
Upside: +354.55%
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.25
Upside: -
Nov 7, 2025
Suspends: Buy
Price Target: $15
Current: $5.40
Upside: +177.78%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.01
Upside: -